
CryoPort (CYRX) Stock Forecast & Price Target
CryoPort (CYRX) Analyst Ratings
Bulls say
CryoPort is well positioned to benefit from the growing cell and gene therapy market, with a strong focus on providing temperature-controlled logistics services. The company has a robust customer base and a long runway for revenue growth, as evidenced by its expanding portfolio of supported therapies and clinical customers. With an increasing number of commercial approvals expected, CryoPort is likely to see strong revenue growth and further margin expansion. The company's strong financial performance and potential for future growth make it an attractive investment option in the life sciences industry.
Bears say
CryoPort is experiencing competition in the market and faces uncertainty in the advancement of cell and gene therapies, which may limit their revenue growth potential and negatively impact their financial outlook. Additionally, their current valuation is relatively high compared to their small/mid-cap growth and life sciences tools and diagnostics peers, which could lead to a decrease in stock price.
This aggregate rating is based on analysts' research of CryoPort and is not a guaranteed prediction by Public.com or investment advice.
CryoPort (CYRX) Analyst Forecast & Price Prediction
Start investing in CryoPort (CYRX)
Order type
Buy in
Order amount
Est. shares
0 shares